Chromogranins have been characterized in mammals a few decades ago and are
routinely used as markers for neuroendocrine tumours. Structural characteri
stics of these proteins as well as experimental data suggest that chromogra
nins may serve as precursors to biologically active peptides. Recently, the
cloning of the cDNAs encoding chromogranins in amphibians and fish reveale
d the occurrence of highly conserved regions that are delimited by cleavage
sites. These regions give rise to peptides in vivo which may represent the
functional determinants of chromogranins. A consent characteristic of chro
mogranins in all species is their specific expression in neuroendocrine cel
ls. Ln the case of neuroendocrine neoplasia, the detection and the measurem
ent of concentrations of chromogranin-derived peptides may improve the diag
nosis and the prognosis of some of these tumours.